Swiss Steel Holding successfully completes EUR 300m capital increase
Niederer Kraft Frey acted as legal counsel to Swiss Steel Holding AG on its EUR 300 million capital increase and all related corporate law matters and proceedings before the Swiss Takeover Board, as well as in the renegotiation of the Group’s existing debt.
Galderma secures USD 3.65bn financing
Niederer Kraft Frey advised the banking syndicate on a USD 3.65 billion term and revolving credit facilities agreement for Galderma group in connection with its successful IPO on SIX Swiss Exchange on 22 March 2024.
Breitling announces its partnership with Climate Impulse
Niederer Kraft Frey advised Climate Impulse on its partnership agreement with Breitling.
Clariant places dual tranche CHF 200m and CHF 150m senior bonds maturing 2027 and 2031
Niederer Kraft Frey advised Clariant AG on the placement of a CHF 200 million bond with a term to maturity of three years (Tranche A) and a CHF 150 million bond with a term to maturity of seven years (Tranche B).
Smart Building & Industrial Services GmbH acquires Swibox Holding AG
Niederer Kraft Frey advised EOS Partners GmbH on the acquisition of Swibox Holding AG by Smart Building & Industrial Services GmbH.
Phoenix Technologies collaborates with IBM to offer a unique and sovereign AI solution and state-of-the-art AI infrastructure in Switzerland
Niederer Kraft Frey acted as legal advisor to Phoenix Technologies AG in the negotiations and the conclusion of an AI collaboration agreement with IBM.
SpineArt secures more than CHF 20m in convertible financing
Niederer Kraft Frey advised SpineArt on its CHF 20 million convertible financing.
Galderma successfully launches its IPO on SIX Swiss Exchange
Niederer Kraft Frey advised a syndicate of 15 banks, led by Goldman Sachs, Morgan Stanley and UBS as joint global coordinators, in connection with the initial public offering of Galderma Group AG that launched on 13 March 2024.
MANDI invests in Cultivated Biosciences
Niederer Kraft Frey acted as counsel to Mandi Ventures (MANDI) on its investment in Cultivated Biosciences SA.
abrantix announces the joint venture PaytestLab with B2 Payment Solutions
Niederer Kraft Frey advised abrantix AG on its joint venture with B2 Payment Solutions Inc.